Surrogacy Market Report 2026

The surrogacy market size has grown rapidly in recent years. It will grow from $19.37 billion in 2025 to $22.88 billion in 2026 at a compound annual growth rate (CAGR) of 18.1%. The growth in the historic period can be attributed to increasing infertility rates, growing acceptance of assisted reproductive technologies, expansion of fertility clinic networks, improved success rates of ivf procedures, rising awareness of alternative family-building options.

The surrogacy market size is expected to see rapid growth in the next few years. It will grow to $43.6 billion in 2030 at a compound annual growth rate (CAGR) of 17.5%. The growth in the forecast period can be attributed to increasing demand for personalized reproductive solutions, rising use of genetic screening in surrogacy, expansion of regulated surrogacy frameworks, growing integration of digital fertility platforms, increasing investment in reproductive healthcare services. Major trends in the forecast period include increasing demand for gestational surrogacy services, rising adoption of advanced ivf technologies, growing use of digital fertility management platforms, expansion of cross-border surrogacy arrangements, enhanced focus on ethical and legal compliance.

The rising prevalence of infertility is expected to drive the growth of the surrogacy market in the coming years. Infertility is defined as the inability to achieve pregnancy after 12 months or more of regular, unprotected sexual intercourse. Surrogacy offers an alternative to traditional pregnancy for individuals or couples who are unable to conceive naturally or carry a pregnancy to term. For example, in April 2023, according to the World Health Organization, a Switzerland-based intergovernmental organization, roughly 17.5% of adults worldwide, or about 1 in 6 individuals, experience infertility, highlighting the urgent need to improve access to affordable, high-quality fertility care for those seeking assistance. Therefore, the rising infertility rates are driving the expansion of the surrogacy market.

Key players in the surrogacy market are concentrating on developing innovative solutions, such as surrogacy.com, to support surrogates and their families throughout every stage of the surrogacy process. Surrogacy.com is a platform and community designed for future surrogates, current surrogates, and advocates, offering resources and guidance for those involved in surrogacy. For instance, in November 2023, Northstar Fertility, a US-based provider of egg donor and fertility services, launched surrogacy.com, a platform created by surrogates themselves. It shares the first-hand experiences and insights of experienced surrogates and connects them with the tools and community needed to successfully navigate the surrogacy journey.

In June 2024, Progyny Inc., a US-based provider of employer-focused fertility benefits, acquired Apryl for an undisclosed amount. Through this acquisition, Progyny aims to strengthen its presence in the European market, enhance its digital fertility benefits offerings, and provide employers with more comprehensive solutions to support employee family-building needs. Apryl is a Germany-based fertility benefits platform that delivers fertility benefits management and digital tools for employee family planning.

Major companies operating in the surrogacy market are Care Fertility Group, Nova IVI Fertility, IVIRMA, Houston Fertility Center, Circle Surrogacy, Ovation Fertility, ConceiveAbilities, Oasis Center, New Hope Fertility Center, Growing Generations, Family Creations, Bourn Hall Clinic, AVA Clinic Scanfert, Clinic Scanfert, Extraordinary Conceptions, Surrogate Solutions, Simple Surrogacy, Gift of Life Surrogacy Agency, ART Reproductive Center, Conceptual Options, New Life Global Network, Reproductive Possibilities, Surrogacy America, Surrogacy Center India.

North America was the largest region in the surrogacy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surrogacy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the surrogacy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the surrogacy market indirectly by increasing costs of imported medical equipment, fertility drugs, laboratory instruments, and digital health technologies used in assisted reproductive procedures. Fertility clinics in North America and Europe are most affected due to reliance on imported IVF equipment and pharmaceuticals, while Asia-Pacific faces pricing pressure on cross-border medical services. These tariffs are contributing to higher overall treatment costs. However, they are also encouraging domestic production of fertility-related medical supplies and localized service delivery models, supporting long-term market stability.

The surrogacy market research report is one of a series of new reports that provides surrogacy market statistics, including surrogacy industry global market size, regional shares, competitors with a surrogacy market share, detailed surrogacy market segments, market trends and opportunities, and any further data you may need to thrive in the surrogacy industry. This surrogacy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Surrogacy is a reproductive arrangement in which a woman, called the surrogate mother, carries and delivers a child on behalf of another individual or couple. It is a key method of assisted reproductive technology, offering a solution for those who are unable to conceive naturally or carry a pregnancy to term.

The main types of surrogacy are gestational surrogacy and traditional surrogacy. Gestational surrogacy involves a woman, known as the gestational surrogate, carrying and giving birth to a child for another person or couple. Technologies such as in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI), IVF without ICSI, and intrauterine insemination are used in various applications by fertility clinics, surrogacy agencies, and surrogacy lawyers.

The surrogacy market consists of revenues earned by entities by providing services such as legal services, medical services, psychological and counseling services, egg or sperm donation services, logistical and coordination services, insurance services, escrow services, and translation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The surrogacy market also includes sales of in-vitro fertilization (IVF) equipment, intrauterine insemination (IUI) equipment, embryo transfer devices and monitoring and evaluation equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.